Bindi Sohal

2.0k total citations
38 papers, 1.5k citations indexed

About

Bindi Sohal is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Bindi Sohal has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Bindi Sohal's work include Neuroscience and Neuropharmacology Research (16 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Drug Transport and Resistance Mechanisms (5 papers). Bindi Sohal is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Drug Transport and Resistance Mechanisms (5 papers). Bindi Sohal collaborates with scholars based in United Kingdom, United States and Switzerland. Bindi Sohal's co-authors include Gareth Williams, Rachel L. Jones, Nigel J. Waters, John Atack, José L. Castro, Rowan Stringer, Keith A. Wafford, Andrew Pike, Peter Kilford and Aleksandra Galetin and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bindi Sohal

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bindi Sohal United Kingdom	19	608	466	389	221	190	38	1.5k
Maria João Bonifácio Portugal	21	605 1.0×	360 0.8×	169 0.4×	123 0.6×	87 0.5×	85	1.7k
Christopher L. Shaffer United States	23	780 1.3×	386 0.8×	233 0.6×	357 1.6×	207 1.1×	56	1.8k
Robert E. Burrier United States	23	855 1.4×	233 0.5×	363 0.9×	66 0.3×	301 1.6×	37	2.0k
Frank E. Blaney United Kingdom	19	1.0k 1.7×	720 1.5×	343 0.9×	370 1.7×	207 1.1×	41	1.9k
F. Gualtieri Italy	18	645 1.1×	390 0.8×	177 0.5×	56 0.3×	255 1.3×	68	1.5k
H. J. Kupferberg United States	21	956 1.6×	1.0k 2.2×	725 1.9×	149 0.7×	191 1.0×	43	2.6k
James C. Barrow United States	29	1.2k 1.9×	429 0.9×	823 2.1×	70 0.3×	120 0.6×	68	2.4k
Károly Tihanyi Hungary	19	436 0.7×	409 0.9×	87 0.2×	118 0.5×	176 0.9×	51	1.4k
Harvey J. Kupferberg United States	25	687 1.1×	1.2k 2.7×	233 0.6×	140 0.6×	254 1.3×	55	2.8k
Anna L. Blobaum United States	29	1.2k 2.0×	888 1.9×	691 1.8×	217 1.0×	190 1.0×	97	2.6k

Countries citing papers authored by Bindi Sohal

Since Specialization

Citations

This map shows the geographic impact of Bindi Sohal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bindi Sohal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bindi Sohal more than expected).

Fields of papers citing papers by Bindi Sohal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bindi Sohal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bindi Sohal. The network helps show where Bindi Sohal may publish in the future.

Co-authorship network of co-authors of Bindi Sohal

This figure shows the co-authorship network connecting the top 25 collaborators of Bindi Sohal. A scholar is included among the top collaborators of Bindi Sohal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bindi Sohal. Bindi Sohal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argikar, Upendra A., et al.. (2017). Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet?. Journal of Pharmaceutical Sciences. 106(9). 2276–2281. 17 indexed citations

Jones, Peter Lloyd, Nicholas Duggan, Denise Head, et al.. (2013). An Inhibitor of NADPH Oxidase-4 Attenuates Established Pulmonary Fibrosis in a Rodent Disease Model. American Journal of Respiratory Cell and Molecular Biology. 50(1). 158–169. 96 indexed citations

Atack, John, Waisi Eng, Christine Ryan, et al.. (2009). The plasma–occupancy relationship of the novel GABA_Areceptor benzodiazepine site ligand, α5IA, is similar in rats and primates. British Journal of Pharmacology. 157(5). 796–803. 10 indexed citations

Kilford, Peter, Rowan Stringer, Bindi Sohal, J. Brian Houston, & Aleksandra Galetin. (2008). Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes. Drug Metabolism and Disposition. 37(1). 82–89. 150 indexed citations

Waters, Nigel J., Rachel L. Jones, Gareth Williams, & Bindi Sohal. (2008). Validation of a Rapid Equilibrium Dialysis Approach for the Measurement of Plasma Protein Binding. Journal of Pharmaceutical Sciences. 97(10). 4586–4595. 240 indexed citations

Pike, Andrew, Susan M. Cook, Alan P. Watt, et al.. (2007). Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands. Biopharmaceutics & Drug Disposition. 28(6). 275–282. 2 indexed citations

Sparey, Tim, Earl E. Clarke, Timothy Harrison, et al.. (2007). Sulfonamide derivatives of bridgehead substituted bicyclo[4.2.1]nonanes as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 375–379. 7 indexed citations

Atack, John, Andy Pike, Susan M. Cook, et al.. (2006). RAT PHARMACOKINETICS AND PHARMACODYNAMICS OF A SUSTAINED RELEASE FORMULATION OF THE GABAA α5-SELECTIVE COMPOUND L-655,708. Drug Metabolism and Disposition. 34(5). 887–893. 19 indexed citations

McDonald, Louise, et al.. (2006). Gaboxadol, a selective extrasynaptic GABAA agonist, does not generalise to other sleep-enhancing drugs: A rat drug discrimination study. Neuropharmacology. 52(3). 844–853. 6 indexed citations

10.

Elliott, Jason, Robert W. Carling, Gary G. Chicchi, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 16(22). 5752–5756. 15 indexed citations

11.

Meneses‐Lorente, Georgina, Claire Guyomard, Christophe Chesné, et al.. (2006). Utility of Long-Term Cultured Human Hepatocytes as an in Vitro Model for Cytochrome P450 Induction. Drug Metabolism and Disposition. 35(2). 215–220. 16 indexed citations

12.

Elliott, Jason, Robert W. Carling, Mark S. Chambers, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(22). 5748–5751. 35 indexed citations

13.

Atack, John, Keith A. Wafford, Spencer J. Tye, et al.. (2005). TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates. Journal of Pharmacology and Experimental Therapeutics. 316(1). 410–422. 156 indexed citations

14.

Sparey, Tim, Dirk Beher, Jonathan D. Best, et al.. (2005). Cyclic sulfamide γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(19). 4212–4216. 44 indexed citations

15.

Sternfeld, Francine, Robert W. Carling, Richard A. Jelley, et al.. (2004). Selective, Orally Active γ-Aminobutyric Acid _A α5 Receptor Inverse Agonists as Cognition Enhancers. Journal of Medicinal Chemistry. 47(9). 2176–2179. 92 indexed citations

16.

Crawforth, James, John Atack, Susan M. Cook, et al.. (2004). Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands. Bioorganic & Medicinal Chemistry Letters. 14(7). 1679–1682. 11 indexed citations

17.

Street, Leslie J., Francine Sternfeld, Richard A. Jelley, et al.. (2004). Synthesis and Biological Evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and Analogues as Subtype-Selective Inverse Agonists for the GABA_Aα5 Benzodiazepine Binding Site. Journal of Medicinal Chemistry. 47(14). 3642–3657. 61 indexed citations

18.

Russell, Michael G. N., Margaret S. Beer, Josephine A. Stanton, et al.. (1999). 2,7-Diazabicyclo[3.3.0]octanes as novel h5-HT1D receptor agonists. Bioorganic & Medicinal Chemistry Letters. 9(17). 2491–2496. 17 indexed citations

19.

Carling, Robert W., Kevin W. Moore, Christopher R. Moyes, et al.. (1999). 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D₄Receptor with Excellent Selectivity over Ion Channels. Journal of Medicinal Chemistry. 42(14). 2706–2715. 50 indexed citations

20.

Sternfeld, Francine, Raymond Baker, Howard B. Broughton, et al.. (1996). The chemical evolution of N,N-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethylamine (L-741,604) and analogues: Potent and selective agonists for 5-HT1D receptors. Bioorganic & Medicinal Chemistry Letters. 6(15). 1825–1830. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact